Toward Personalized Decision Support Systems for Type 1 Diabetes: Integrating Psychobehavioral Factors and Glycemic Control.

IF 3.7 Q2 ENDOCRINOLOGY & METABOLISM
Mohammadreza Ganji, Leela Krishna Chaitanya Koravi, Marc Breton, Chiara Fabris
{"title":"Toward Personalized Decision Support Systems for Type 1 Diabetes: Integrating Psychobehavioral Factors and Glycemic Control.","authors":"Mohammadreza Ganji, Leela Krishna Chaitanya Koravi, Marc Breton, Chiara Fabris","doi":"10.1177/19322968251359641","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While novel technologies have improved glycemic control in type 1 diabetes (T1D), their design is often glucose-centric and overlooks critical psychobehavioral elements such as individual treatment preferences and therapeutic goals. This article presents an algorithm development framework and study layout aimed at incorporating psychobehavioral factors into the design of technology for the management of T1D.</p><p><strong>Methods/design: </strong>A decision support system (DSS) was engineered at the University of Virginia providing therapeutic advice to individuals with T1D regarding optimal insulin dosing parameters, bolus calculation, safe undertaking of physical activity, and risk for hypoglycemia during the day as well as at bedtime. To accommodate individual preferences as to how the therapeutic advice is delivered, the DSS was designed with two possible operating modalities: <i>prescriptive</i>-offering optimized therapeutic recommendations for structured guidance, and <i>informative</i>-providing users with actionable insights to support informed decision-making. To test the DSS, a randomized crossover clinical trial design is described, where participants are sequentially exposed to each modality in random order. Throughout the study, glycemic control is captured by continuous glucose monitors, while patient-reported outcomes are assessed through psychometric evaluations.</p><p><strong>Conclusion: </strong>This work introduces a novel framework for the design of personalized DSS technology capable of tailoring the delivery mode of therapeutic insights to each user's preferences. By integrating psychobehavioral factors into algorithm design, this work seeks to advance the development of adaptive, user-centric technologies that can enhance both clinical outcomes and patient quality of life.</p>","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":" ","pages":"1172-1182"},"PeriodicalIF":3.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968251359641","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: While novel technologies have improved glycemic control in type 1 diabetes (T1D), their design is often glucose-centric and overlooks critical psychobehavioral elements such as individual treatment preferences and therapeutic goals. This article presents an algorithm development framework and study layout aimed at incorporating psychobehavioral factors into the design of technology for the management of T1D.

Methods/design: A decision support system (DSS) was engineered at the University of Virginia providing therapeutic advice to individuals with T1D regarding optimal insulin dosing parameters, bolus calculation, safe undertaking of physical activity, and risk for hypoglycemia during the day as well as at bedtime. To accommodate individual preferences as to how the therapeutic advice is delivered, the DSS was designed with two possible operating modalities: prescriptive-offering optimized therapeutic recommendations for structured guidance, and informative-providing users with actionable insights to support informed decision-making. To test the DSS, a randomized crossover clinical trial design is described, where participants are sequentially exposed to each modality in random order. Throughout the study, glycemic control is captured by continuous glucose monitors, while patient-reported outcomes are assessed through psychometric evaluations.

Conclusion: This work introduces a novel framework for the design of personalized DSS technology capable of tailoring the delivery mode of therapeutic insights to each user's preferences. By integrating psychobehavioral factors into algorithm design, this work seeks to advance the development of adaptive, user-centric technologies that can enhance both clinical outcomes and patient quality of life.

针对1型糖尿病的个性化决策支持系统:整合心理行为因素和血糖控制。
背景:虽然新技术改善了1型糖尿病(T1D)的血糖控制,但它们的设计往往以血糖为中心,忽视了关键的心理行为因素,如个体治疗偏好和治疗目标。本文提出了一种算法开发框架和研究布局,旨在将心理行为因素纳入T1D管理的技术设计中。方法/设计:弗吉尼亚大学设计了一个决策支持系统(DSS),为T1D患者提供有关最佳胰岛素剂量参数、丸量计算、安全进行体力活动以及白天和睡前低血糖风险的治疗建议。为了适应个人对如何提供治疗建议的偏好,DSS设计了两种可能的操作模式:处方性-为结构化指导提供优化的治疗建议,信息性-为用户提供可操作的见解,以支持知情决策。为了测试DSS,描述了一个随机交叉临床试验设计,其中参与者按随机顺序依次暴露于每种模式。在整个研究过程中,血糖控制通过连续血糖监测仪进行监测,而患者报告的结果则通过心理测量评估进行评估。结论:这项工作为个性化DSS技术的设计引入了一个新的框架,能够根据每个用户的偏好定制治疗见解的交付模式。通过将心理行为因素整合到算法设计中,这项工作旨在推动自适应、以用户为中心的技术的发展,从而提高临床结果和患者的生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes Science and Technology
Journal of Diabetes Science and Technology Medicine-Internal Medicine
CiteScore
7.50
自引率
12.00%
发文量
148
期刊介绍: The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信